We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current FMCQF market cap is 13.32B. The company's latest EPS is EUR and P/E is N/A.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 17.48B | 17.86B | 17.62B | 19.4B | 19.45B |
| Operating Income | 2.27B | 2.3B | 1.85B | 1.36B | 1.4B |
| Net Income | 1.2B | 1.16B | 969.31M | 673.41M | 499M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 32.93B | 31.69B | 34.37B | 35.75B | 33.93B |
| Total Liabilities | 19.71B | 19.36B | 20.39B | 20.3B | 19.1B |
| Total Equity | 13.23B | 12.33B | 13.98B | 15.45B | 14.83B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 2.57B | 4.23B | 2.49B | 2.17B | 2.63B |
| Investing | -3.29B | -1.33B | -1.2B | -734.73M | -544.23M |
| Financing | -466.63M | -2.66B | -1.02B | -1.62B | -1.86B |
| Market Cap | 13.32B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | 2.52% |
| Shares Outstanding | 293.41M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 6.74k |
| 52 Week Change | 9.43% |
| 52 Week High | 48.19 |
| 52 Week Low | 35.45 |
| Spread (Intraday) | 4.28 (8.92%) |
| Company Name | Fresenius Med Care (PK) |
| Address |
else-kr��ner-strasse 1 bad homburg vor der hoehe 61352 |
| Website | https://www.fmc-ag.de |
| Industry | hospital & medical svc plans (6324) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
